The executive team at Affimed has a wealth of experience in the biotech and pharmaceutical industry. The CEO has experience securing investment and launching spin-offs, while the CCO has experience commercializing drugs and key player in Shire's M&A process. Other members of the team have experience working at Carl-Zeiss, Novartis, and Metanomics Health. The team is also educated, with degrees in Carcinogenesis, Oncology, and Biology.
View all